Shenluo Medical is a developer of active neuroimplantable medical devices. Based on innovative technology research and development in the field of neuromodulation, the company is committed to providing more advanced and effective treatment methods for patients with pain, epilepsy, and heart failure, and is committed to neurostimulation. product development and production. At present, the products under development are three types of active nerve implantable medical devices – spinal cord nerve stimulator SCS and short-term implantable peripheral nerve stimulation PNS. Recently, Shenluo Medical completed nearly 100 million yuan in Series B financing. This round of financing was led by SDIC Chuanghe, and the old shareholder Boyuan Capital continued to invest more. The financing funds will be used for new product development, clinical research, registration applications, and chip iterations.
This article is reproduced from: https://www.itjuzi.com/investevent/13617070
This site is for inclusion only, and the copyright belongs to the original author.